Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokine release syndrome and cancer immunotherapies – historical challenges and promising futures
Deep Shah, Brian W. Soper, Lindsay S. Shopland
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Beyond Chemoimmunotherapy in Advanced Non–Small Cell Lung Cancer: New Frontiers, New Challenges
Giannis Mountzios, Jarushka Naidoo, Chao Wang, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 11
Bispecific antibodies: advancing precision oncology
M. Zurita Herrera, G. Pretelli, Jayesh Desai, et al.
Trends in cancer (2024) Vol. 10, Iss. 10, pp. 893-919
Open Access | Times Cited: 11
Comprehensive Review of Early and Late Toxicities in CAR T-Cell Therapy and Bispecific Antibody Treatments for Hematologic Malignancies
Ayrton Bangolo, Behzad Amoozgar, Charlene Mansour, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 282-282
Open Access | Times Cited: 1
A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings
Steven P. Treon, Camille N. Kotton, Jae‐Hyun Park, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Gasdermin-E-mediated pyroptosis drives immune checkpoint inhibitor-associated myocarditis via cGAS-STING activation
Si-Jia Sun, Xiao‐Dong Jiao, Zhigang Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study
Massimiliano Camilli, Marcello Viscovo, Tamara Felici, et al.
Cardio-Oncology (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
3,6-Anhydro-L-galactose suppresses mouse lymphocyte proliferation by attenuating JAK-STAT growth factor signal transduction and G1-S cell cycle progression
Shin Young Park, Ki Yun Kim, Won Young Jang, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113998-113998
Open Access
IL-8 Downregulation Mediates the Beneficial Effects of Infection-Induced Fever on Breast Cancer Prognosis
Heliang Li, Xinyan Liang, Jiafan Ma, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 405-419
Open Access
Clinical and Proteomic Insights into a Cytokine Release Syndrome Triggered by Tebentafusp in a Metastatic Uveal Melanoma Patient: Case Report
Antonio David Lazaro Sanchez, Javier David Benítez Fuentes, Ginés Luengo‐Gil, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1333-1333
Open Access
Advances in Gene Therapy with Oncolytic Viruses and CAR-T Cells and Therapy-Related Groups
Yasunari Matsuzaka, Ryu Yashiro
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 268-268
Open Access
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathways
Alexander Mazein, Muhammad Shoaib, Miriam Alb, et al.
Journal of Immunotoxicology (2024) Vol. 21, Iss. sup1
Open Access | Times Cited: 4
Mechanistic PKPD modeling to describe cytokine release associated with CD3 T-cell engager therapies
Apolline Lefèvre, Zinnia P. Parra‐Guillén, Iñaki F. Trocóniz, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
“Innate Immune Cell Engagers: Matchmakers for Next-Generation Immunotherapy”
Sascha Cording, Jens Pahl, Kristina Ellwanger, et al.
Springer eBooks (2025), pp. 1-25
Closed Access
Late-onset and relapsed cytokine release syndrome after nivolumab treatment in a patient with head and neck squamous cell carcinoma: a case report
Tomoyuki Otsuka, Yoshiki Kojitani, Fumio Imamura, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment
H. In, Minkyoung Park, H.-K. Lee, et al.
Antibodies (2025) Vol. 14, Iss. 1, pp. 16-16
Open Access
A phase I dose-escalation and expansion study of RMX1002, a selective E-type prostanoid receptor 4 antagonist, as monotherapy and in combination with anti-PD-1 antibody in advanced solid tumors
Dan Liu, Jifang Gong, Jian Zhang, et al.
Investigational New Drugs (2025)
Open Access
The Dual Role of Chaperone-mediated Autophagy in the Response and Resistance to Cancer Immunotherapy
Mohammadreza Saberiyan, Sarah Gholami, Mahsa Ejlalidiz, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 210, pp. 104700-104700
Open Access
T-ing up the storm: pathogenic cycling lymphocytes in the biology of macrophage activation syndrome
Michael T. Lam, Connie Jiang, Pui Y. Lee
Pediatric Rheumatology (2025) Vol. 23, Iss. 1
Open Access
Resistance in Lung Cancer Immunotherapy and How to Overcome It: Insights from the Genetics Perspective and Combination Therapies Approach
Paweł Zieliński, Maria Stępień, Hanna Chowaniec, et al.
Cells (2025) Vol. 14, Iss. 8, pp. 587-587
Open Access
Better safe than sorry: dual targeting antibodies for cancer immunotherapy
Katrin Schoenfeld, Julia Harwardt, Harald Kolmar
Biological Chemistry (2024) Vol. 405, Iss. 7-8, pp. 443-459
Closed Access | Times Cited: 3
Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors
Ravit Geva, María Vieito, Jorge Ramón, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 10
Open Access | Times Cited: 3
Pharmacokinetics and safety of LEAD-452, an EGFR-specific 4-1BB-agonistic trimerbody in non-human primates
Rocío Navarro, Susana Frago, Oana Hangiu, et al.
Toxicology and Applied Pharmacology (2024) Vol. 487, pp. 116961-116961
Open Access | Times Cited: 2
Cytokine Release Syndrome in Chimeric Antigen Receptor T Cell Therapy and Coagulopathies
Haoming Tang, Yi Xin Li, Samuel Sherng Young Wang
Interdisciplinary cancer research (2024)
Closed Access | Times Cited: 1
Pharmacotherapy considerations in patients who develop acute kidney injury during anti-cancer therapy
E Parodi, Maura Rossi, Achille Bottiglieri, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 5, pp. 595-610
Closed Access | Times Cited: 1
Molecular understanding and clinical outcomes of CAR T cell therapy in the treatment of urological tumors
Gong Zhang, Yuan Wang, Shiyang Lu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top